From February 14, 2024 to March 15, 2024, the company has repurchased 190,000 shares, representing 0.29% for DKK 378.72 million. With this, the company has completed the repurchase of 190,000 shares, representing 0.29% for DKK 378.72 million under the buyback announced on February 14, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,003 DKK | -0.45% | +1.91% | -7.05% |
03/05 | GENMAB : A good start to 2024; guidance unchanged | |
03/05 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.05% | 18.64B | |
+2.93% | 108B | |
-5.27% | 23.46B | |
-14.60% | 21.72B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B | |
-24.02% | 8.32B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Tranche Update on Genmab A/S's Equity Buyback Plan announced on February 14, 2024.